Ηear from Dr. George Scangos, CEO of Vir Biotechnology, about how Vir combines immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, one of the leading causes of death worldwide. Vir is tackling the world’s largest and most serious infectious diseases, infections that are evasive, challenging, or insufficiently addressed by current approaches, including hepatitis B, influenza A, SARS-CoV-2, HIV, and tuberculosis.
Speaker:
Dr. George Scangos, CEO, Vir Biotechnology & Former CEO, Biogen
Moderator:
Anna Protopapas, CEO Mersana Therapeutics
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More